The Impact of Adherence to Disease-Modifying Therapies on Functional Outcomes in Veterans with Multiple Sclerosis
Background: Patients who adhere to their DMTs have lower rate of MS-related relapses and disability. Objective: We sought to determine the adherence rate to disease-modifying therapies (DMTs) and its impact on functional outcome(s) in veterans with multiple sclerosis (MS). Method: We reviewed the el...
Main Authors: | Meheroz H Rabadi, Kimberly Just, Chao Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2021-07-01
|
Series: | Journal of Central Nervous System Disease |
Online Access: | https://doi.org/10.1177/11795735211028769 |
Similar Items
-
Adherence to disease-modifying therapies in patients with multiple sclerosis
by: Kołtuniuk A, et al.
Published: (2018-08-01) -
Patient choice and adherence with disease-modifying therapy in multiple sclerosis
by: Burke, G, et al.
Published: (2004) -
Predictors of adherence and persistence to disease-modifying therapies in Multiple Sclerosis
by: Gisela Zanga, et al.
Published: (2021-10-01) -
Psychosocial predictors of patient adherence to disease-modifying therapies for multiple sclerosis
by: Alosaimi FD, et al.
Published: (2017-03-01) -
Acceptability and outcomes of an individualized exergaming telePT program for veterans with multiple sclerosis: a pilot study
by: Shane Chanpimol, et al.
Published: (2020-10-01)